1. Home
  2. MTH vs MDGL Comparison

MTH vs MDGL Comparison

Compare MTH & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTH
  • MDGL
  • Stock Information
  • Founded
  • MTH 1985
  • MDGL 2011
  • Country
  • MTH United States
  • MDGL United States
  • Employees
  • MTH N/A
  • MDGL N/A
  • Industry
  • MTH Homebuilding
  • MDGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTH Consumer Discretionary
  • MDGL Health Care
  • Exchange
  • MTH Nasdaq
  • MDGL Nasdaq
  • Market Cap
  • MTH 6.9B
  • MDGL 7.4B
  • IPO Year
  • MTH 1988
  • MDGL N/A
  • Fundamental
  • Price
  • MTH $154.61
  • MDGL $308.44
  • Analyst Decision
  • MTH Hold
  • MDGL Buy
  • Analyst Count
  • MTH 9
  • MDGL 14
  • Target Price
  • MTH $193.71
  • MDGL $347.33
  • AVG Volume (30 Days)
  • MTH 514.9K
  • MDGL 355.8K
  • Earning Date
  • MTH 01-29-2025
  • MDGL 10-31-2024
  • Dividend Yield
  • MTH 1.94%
  • MDGL N/A
  • EPS Growth
  • MTH 2.15
  • MDGL N/A
  • EPS
  • MTH 22.10
  • MDGL N/A
  • Revenue
  • MTH $6,433,727,000.00
  • MDGL $76,813,000.00
  • Revenue This Year
  • MTH $4.39
  • MDGL N/A
  • Revenue Next Year
  • MTH $8.35
  • MDGL $194.49
  • P/E Ratio
  • MTH $7.00
  • MDGL N/A
  • Revenue Growth
  • MTH N/A
  • MDGL N/A
  • 52 Week Low
  • MTH $147.77
  • MDGL $168.25
  • 52 Week High
  • MTH $213.98
  • MDGL $368.29
  • Technical
  • Relative Strength Index (RSI)
  • MTH 28.05
  • MDGL 51.11
  • Support Level
  • MTH $150.44
  • MDGL $289.80
  • Resistance Level
  • MTH $186.51
  • MDGL $315.09
  • Average True Range (ATR)
  • MTH 5.56
  • MDGL 12.44
  • MACD
  • MTH -3.16
  • MDGL -4.11
  • Stochastic Oscillator
  • MTH 10.00
  • MDGL 48.58

About MTH Meritage Homes Corporation

Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, which are comprised of ten states: Arizona, California, Colorado, Texas, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Utah. The company operates with two principal business segments; homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes and providing warranty and customer services and the financial services segment offer title and escrow, mortgage, and insurance services. The company generates key revenue from the homebuilding segment.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.

Share on Social Networks: